Standpoint Research Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Hold
Tweet Send to a Friend
Standpoint Research downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Buy to Hold.
"Our February 26, 2010 recommendation ENDP is up ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
"Our February 26, 2010 recommendation ENDP is up ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
